BioSpace News Archive

Business

Seres Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates

Seres Therapeutics, Inc., a leading microbiome company developing a novel class of multifunctional bacterial therapeutics designed to functionally interact with host cells and tissues to treat disease, reported second quarter 2021 financial results and provided business updates.

August 3, 2021
·
16 min read
Drug Development

Arcturus Announces Approval of Singapore Clinical Trial Application to Advance ARCT-154 and ARCT-165, Next Generation STARR™ mRNA Vaccines Targeting SARS-CoV-2 Variants of Concern, in a Phase 1/2 Study

Arcturus Therapeutics Holdings Inc. announced that the Company has received approval for a Clinical Trial Application from the Singapore Health Sciences Authority to enable the advancement of two STARR™ mRNA vaccine candidates into the clinic.

August 3, 2021
·
5 min read
Business

Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Incyte reports 2021 second quarter financial results and provides a status update on the Company’s development portfolio.

August 3, 2021
·
29 min read
Antibe Therapeutics Provides Clinical Update for Otenaproxesul

Antibe Therapeutics Inc. has placed its absorption, metabolism and excretion (“AME”) study of otenaproxesul on a required pause because a pre-specified safety threshold was exceeded.

August 3, 2021
·
4 min read
Policy

Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System

Aurora Spine Corporation, a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced it had received U.S. Food and Drug Administration 510 Clearance for its DEXA-C, a new line of cervical cages for anterior cervical discectomy with fusion procedures.

August 3, 2021
·
4 min read
Business

Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercialization of Ganaxolone

Orion obtains rights to commercialize both the oral and IV franchises of ganaxolone in Europe. Collaboration supports mid-2022 European launch of oral ganaxolone for CDKL5 deficiency disorder, if approved; leverages Orion’s expertise in rare orphan diseases, antiepileptics and European commercialization

August 3, 2021
·
9 min read
Business

OpGen Achieves Key Development Milestone in Unyvero A30 RQ Platform Program

OpGen, Inc. today announced that its subsidiary Curetis GmbH and its instrument development and engineering partner have assembled 10 final pre-series release analyzer instruments of the Unyvero A30 RQ platform.

August 3, 2021
·
5 min read
Business

StageZero Life Sciences Appoints Matthew J. Pietras as CFO and COO

StageZero Life Sciences, Ltd., a healthcare company working to reduce the risk of cancer and other chronic diseases through early detection and intervention, announced that Matthew J. Pietras has been appointed as Chief Financial Officer and Chief Operating Officer, effective August 28, 2021.

August 3, 2021
·
4 min read
Business

Gennao Bio Appoints Dale L. Ludwig, Ph.D., as Chief Scientific Officer

Gennao Bio today announced the expansion of its executive leadership team with the appointment of Dale L. Ludwig, Ph.D., as chief scientific officer.

August 3, 2021
·
2 min read
Business

Scholar Rock Announces Leadership Change

Nagesh Mahanthappa, Ph.D., MBA, Scholar Rock’s founding chief executive, returns as Interim Chief Executive Officer as CEO Tony Kingsley departs

August 3, 2021
·
6 min read